Singapore
TTSH and life sciences firm to deliver advanced multiple-gene testing
Their clinical research will help lessen testing costs.
Over one-third of Singaporeans cut back health-related expenses
TELUS Health said 65% curtailed their discretionary spending.
Singapore Red Cross now accepts crypto donations
Crypto donations is coursed via crypto payment gateway Triple-A.
Singapore’s healthtech agency rebrands as Synapxe
AI-powered platforms were unveiled as the agency was rechristened.
Singapore launches industry transformation map 2025 for healthcare
Preventive health takes centre stage.
Vacant buildings to turn into hostel accommodation for SG’s foreign HCWs
The retrofitted rooms are for newly employed Singapore public healthcare workers.
IHH Healthcare grants approval for Agilus IPO plans
The timing of the IPO will be determined by Agilus and Fortis.
OUEH’s profit attributable to the company down nearly 80% in H1
Its revenue, however, increased 85% year-on-year (YoY) to $78.7m.
Keeping Mobile Health Apps Free from Bot Diseases
By 2026, Singapore will be a “super-aged” society, with 21% of the population aged 65 and above.
Robot trio augment nursing care in Singapore hospital
Autonomous robots are in charge of wayfinding, medication delivery, and blanket delivery.
Singapore’s Centre for Healthcare Innovation launches initiatives to improve community care
CHI’s HSC Academy and Evaluation Framework complement the Healthier SG initiative.Â
SingHealth expands digital twin tech use for surveillance of disease outbreaks
It is also testing the tech for workflow and facility planning.
Study shows lower-income seniors remain vulnerable to digital ownership
Older adults with lower income status may not own as many digital devices.
Singapore’s healthtech agency deepens tie with US tech giant on AI, cloud innovation
AI-powered innovations and secure cloud platform will help modernise and automate operations in public healthcare
Thomson Medical Group OKs acquisition of Vietnam’s FV Hospital
The acquisition costs $517.1m (US$381.4m).
Singapore Diagnostics revolutionises Philippine healthcare through quality, accessibility, and talent development
Singapore Diagnostics, the Philippine flagship company of Pathology Asia, has improved access to healthcare services with its 40 locations across the nation.